Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies.
Favari C, Rinaldi de Alvarenga JF, Sánchez-Martínez L, Tosi N, Mignogna C, Cremonini E, Manach C, Bresciani L, Del Rio D, Mena P. Favari C, et al. Among authors: mignogna c. Redox Biol. 2024 May;71:103095. doi: 10.1016/j.redox.2024.103095. Epub 2024 Feb 20. Redox Biol. 2024. PMID: 38428187 Free PMC article. Review.
MITO END-3: Efficacy of Avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.
Pignata S, Califano D, Lorusso D, Arenare L, Bartoletti M, De Giorgi U, Andreetta C, Pisano C, Scambia G, Lombardi D, Farolfi A, Cinieri S, Passarelli A, Salutari V, De Angelis C, Mignogna C, Priolo D, Capoluongo ED, Tamberi S, Scaglione GL, Arcangeli V, De Cecio R, Scognamiglio G, Greco F, Spina A, Turinetto M, Russo D, Carbone V, Casartelli C, Schettino C, Perrone F. Pignata S, et al. Among authors: mignogna c. Ann Oncol. 2024 May 2:S0923-7534(24)00128-5. doi: 10.1016/j.annonc.2024.04.007. Online ahead of print. Ann Oncol. 2024. PMID: 38704093
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study.
Maddaloni E, Naciu AM, Mignogna C, Galiero R, Amendolara R, Fogolari M, Satta C, Serafini C, Angeletti S, Cavallo MG, Cossu E, Sasso FC, Buzzetti R, Pozzilli P; LADASAXADAPA study group. Maddaloni E, et al. Among authors: mignogna c. Diabetes Obes Metab. 2024 May;26(5):1670-1677. doi: 10.1111/dom.15469. Epub 2024 Jan 31. Diabetes Obes Metab. 2024. PMID: 38297915 Clinical Trial.
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study.
Maddaloni E, Carlone A, Pitocco D, Leanza G, Suraci C, Altomare M, Cavallo MG, Barchetta I, Morano S, Moretti C, Coraggio L, Visalli N, Tramontana F, Schiaffini R, Crinò A, Buzzetti R, Pozzilli P; IMDIAB study group. Maddaloni E, et al. Diabetes Obes Metab. 2023 Nov;25(11):3415-3419. doi: 10.1111/dom.15213. Epub 2023 Jul 14. Diabetes Obes Metab. 2023. PMID: 38014612 No abstract available.
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
Mantovani A, Morieri ML, Aldigeri R, Palmisano L, Masulli M, Bonomo K, Baroni MG, Cossu E, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Cas AD, de Kreutzenberg SV, Targher G. Mantovani A, et al. Among authors: mignogna c. Diabetes Metab. 2024 Jan;50(1):101497. doi: 10.1016/j.diabet.2023.101497. Epub 2023 Nov 20. Diabetes Metab. 2024. PMID: 37992857 Free article.
Distinctive phenogroup to differentiate diagnosis of cardiac myxoma vs cardiovascular disease examining blood-based circulating cell biomarkers.
Donato G, Mignogna C, Santise G, Presta I, Ferrazzo T, Garo V, Maselli D, Curcio A, De Rosa S, Spaccarotella C, Mollace V, Gentile F, Indolfi C, Malara N. Donato G, et al. Among authors: mignogna c. Sci Rep. 2023 Nov 21;13(1):20357. doi: 10.1038/s41598-023-47639-y. Sci Rep. 2023. PMID: 37990043 Free PMC article.
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.
Csermely A, Mantovani A, Morieri ML, Palmisano L, Masulli M, Cossu E, Baroni MG, Bonomo K, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Aldigeri R, Cas AD, de Kreutzenberg SV, Targher G. Csermely A, et al. Among authors: mignogna c. Diabetes Metab. 2023 Nov;49(6):101477. doi: 10.1016/j.diabet.2023.101477. Epub 2023 Sep 12. Diabetes Metab. 2023. PMID: 37708990
131 results